Welcome to our dedicated page for Bakkt Holdings SEC filings (Ticker: BKKT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bakkt’s crypto-centric disclosures can feel like a labyrinth—fair-value crypto accounting here, loyalty-point liabilities there and pages of evolving regulatory risk. If you have ever asked, “How do I sift through Bakkt’s 10-K for digital asset custody details?� you are not alone.
Stock Titan’s AI-powered analysis breaks those documents into clear, searchable insights. Need the latest Bakkt quarterly earnings report 10-Q filing distilled to operating-segment revenue? It is ready in seconds. Tracking Bakkt insider trading Form 4 transactions before a material 8-K? AGÕæÈ˹ٷ½-time alerts land the moment EDGAR posts. Our platform covers every formâ€�10-K annual reports, 10-Q quarterlies, 8-K material events, S-1 registrations, and Bakkt executive stock transactions Form 4—with AI summaries that explain them simply.
Explore why investors monitor each filing type: 10-Ks outline crypto custody security controls and loyalty-point redemption volumes; 10-Qs update trading-fee trends; 8-Ks flag partnerships that could expand token coverage; the proxy statement details executive compensation in a volatile digital-asset market. Whether you are googling “understanding Bakkt SEC documents with AI� or hunting for a single footnote on digital asset liquidity, our expert commentary and keyword-level search save hours of manual review.
Centene Corporation (CNC) � Form 4 insider filing
Director Kenneth A. Burdick reported a modest open-market acquisition of 556 Centene common shares on 30 June 2025 (transaction code A). The shares were acquired at a stated price of $0.00, suggesting the issuance relates to compensation or dividend reinvestment rather than a cash purchase. Following the transaction, Burdick’s direct ownership increases to 367,052.924 shares. He also reports 86,498 indirect shares held through Burdick Family LLC, bringing his aggregated economic interest to roughly 453.6 thousand shares.
The filing also discloses an existing stock option for 10,000 shares with a strike price of $80.57, exercisable from 7 Feb 2025 and expiring 7 Feb 2032. No new derivative transactions were recorded.
While insider purchases are generally viewed as a confidence signal, the 556-share addition represents less than 0.2 % of Burdick’s current stake and is immaterial to Centene’s overall float. The transaction therefore carries limited fundamental impact but modestly reinforces management–shareholder alignment.
OCI N.V. and its Dutch subsidiaries OCI Intermediate B.V. and OCI Chemicals B.V. have filed a Schedule 13G disclosing a sizeable passive stake in Methanex Corporation (NASDAQ/TSX: MEOH). The filing, triggered by a June 27 2025 event date, shows beneficial ownership of 9,944,308 common shares, equal to 12.9 % of Methanex’s 77,339,520 shares outstanding as of June 30 2025.
All shares are held with shared voting power over 7,726,218 shares � subject to an undertaking not to vote more than 9.99 % of the company’s outstanding stock until Toronto Stock Exchange listing conditions are satisfied � and shared dispositive power over the full 9.94 million-share position. The reporting persons possess no sole voting or dispositive authority, underscoring the filing’s passive intent. Each entity certifies that the securities were not acquired for the purpose of influencing control, in line with Schedule 13G requirements.
The disclosure makes OCI � a Netherlands-based global producer of nitrogen, methanol and hydrogen products � one of Methanex’s largest known shareholders. While the filing does not announce any transaction terms or strategic plans, the scale of the stake (worth roughly US$450-500 million at recent prices) signals institutional confidence in Methanex’s methanol market outlook and could foreshadow future collaboration or corporate activity within the global methanol value chain.
Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is offering Autocallable Barrier Securities maturing 6 July 2027 with a total face amount of $922,000 (1,000-denomination). The unsecured notes are linked to the worst performer of three U.S. equity indices: Nasdaq-100 (22,679.01), Russell 2000 (2,175.035) and S&P 500 (6,204.95).
Key mechanics: 1) Automatic early redemption on 30 Jun 2026 if every index closes at or above its initial level, paying principal plus a 12 % premium ($1,120). 2) If not called, final payout on 30 Jun 2027 depends solely on the worst performer: � Appreciation participates at a 300 % upside rate. � If the worst performer is � initial but � 70 % barrier, only principal is returned. � If it falls below the 70 % barrier, investors lose 1 % of principal for each 1 % decline, up to total loss.
The notes do not pay coupons, are not listed, and carry the credit risk of both CGMHI and Citi. Issue price is $1,000, but the internal estimated value is $980.60; underwriting fee up to $10 per note. CGMI will make a secondary market on a best-efforts basis only.
Risk highlights include potential total loss of investment, reliance on a single worst-performing index, high valuation sensitivity on only two observation dates, liquidity constraints, small-cap volatility in Russell 2000, and uncertain tax treatment. The modest offering size and routine structure suggest limited impact on Citi’s overall financials.
Genpact Limited (NYSE: G) filed an 8-K reporting the appointment of John Hinshaw to its Board of Directors, effective July 1 2025. Hinshaw, 54, brings extensive operations and technology leadership experience from prior senior roles at HSBC (Group COO, 2020-2024), Hewlett-Packard/HPE (EVP Technology & Operations, 2011-2016), Boeing (CIO & GM, 2007-2011) and Verizon (SVP & CIO, Wireless Division). He currently serves as an independent director at Sysco and has held board seats at BNY Mellon and DocuSign.
Under Genpact’s non-employee director compensation program, Hinshaw will receive an annual cash retainer of $70,000 and restricted share units (RSUs) worth $210,000. Because his service begins mid-year, 2025 compensation will be pro-rated to $35,000 cash plus RSUs worth $105,000, valued at the closing share price on the grant date. He also executed the company’s standard director indemnification agreement.
The filing contains no other operational, financial or strategic disclosures.
Bakkt Holdings, Inc. has filed a Form S-8 to register an additional 979,201 Class A shares for issuance under its 2021 Omnibus Incentive Plan, following shareholder approval on 17 June 2025. This brings the total shares registered for the plan to 4,014,123, providing fresh capacity for stock-based compensation to directors, officers, employees and other eligible participants. The filing incorporates by reference the company’s most recent Form 10-K, 10-Q, proxy statement and multiple Form 8-Ks, outlines Delaware indemnification provisions for directors and officers, and supplies an updated exhibit index that includes Amendment No. 3 to the incentive plan and the related legal opinion from Sullivan &Cromwell. No new financial statements or earnings data are presented.
JPMorgan Chase Financial Company LLC is issuing $89,000 of Step-Up Auto Callable Notes linked to the proprietary J.P. Morgan Dynamic BlendSM Index (ticker: JPUSDYBL). The notes priced on 30 Jun 2025, settle 3 Jul 2025, and mature 6 Jul 2028 unless called earlier.
Economic terms
- Denomination: $1,000; CUSIP 48136EPU3.
- Automatic call if the Index closes at or above the Call Value on a review date: 100.5% of initial on 30 Jun 2026 (10% premium) or 101% on 30 Jun 2027 (20% premium).
- If not called, maturity payment equals principal plus 100% of any positive Index return; downside is floored at par.
- No periodic coupons; investors forgo interim income.
- Price to public = $1,000; estimated value = $957.40 (reflecting dealer fees and hedging costs).
Underlying index � a rules-based strategy that reallocates daily between an S&P 500 futures index and 2-year U.S. Treasury futures to target 3% volatility, less a 0.95% annual index deduction. Low volatility targeting means the strategy may hold large bond exposure, potentially muting equity upside.
Risk & structural considerations
- The notes are unsecured obligations of JPMorgan Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; repayment depends on their creditworthiness.
- No listing is planned; secondary liquidity will rely on dealer bids that are expected to be below the issue price.
- Tax counsel expects contingent payment debt instrument treatment, requiring holders to accrue OID at a 5.22% comparable yield.
The product targets investors comfortable with a potential three-year hold, willing to exchange liquidity and interest income for principal protection, limited call premiums, and uncapped participation in any index appreciation at maturity.
Bakkt Holdings, Inc. (BKKT) � Form 4 Insider Transaction
Director Sean Roberts Collins was granted 30,191 restricted stock units (RSUs) of Class A common stock on 17 June 2025. Each RSU converts into one share upon vesting. The award vests 100% on 17 June 2026, contingent on continued service. No cash was paid (reported price $0). Following the grant, Collins� total beneficial ownership rose to 63,431 shares, all held directly, of which the newly issued 30,191 shares remain unvested.
No shares were sold and no derivative securities were reported. The filing signals routine board compensation rather than an open-market purchase or sale, therefore the immediate financial impact on Bakkt’s share supply and insider-sentiment indicators is limited.
Form 4 highlights: On 06/17/2025 Bakkt Holdings, Inc. (BKKT) director Colleen B. Brown received an equity award of 16,543 Class A restricted stock units (RSUs). The RSUs were granted at a cost basis of $0 and will vest 100% on 06/17/2026, contingent on continued service.
Following the grant, Ms. Brown’s total beneficial ownership increased to 31,499 Class A shares, of which the newly granted 16,543 shares remain subject to vesting.
No open-market purchase or sale occurred—this is a standard annual equity grant for a non-employee director, intended to align her interests with shareholders rather than signal a directional view on the stock. The filing discloses no derivative security transactions, option exercises, or dispositions.
For investors, the transaction is non-dilutive in the near term (shares are already reserved under the company’s equity plan) and reflects standard board compensation practice. It adds modest insider alignment but does not materially change share count, cash flows, or guidance.
Bakkt Holdings, Inc. (BKKT) filed a Form 4 reporting that director Jill Simeone received 16,543 restricted stock units (RSUs) of Class A common stock on 17 June 2025 at a grant price of $0. The RSUs are subject to a single-cliff vesting schedule: 100% of the units vest on 17 June 2026, provided the director remains in service. After the award, Simeone now beneficially owns 37,806 shares, of which 16,543 are still unvested RSUs. No open-market purchases, sales, or derivative transactions were disclosed, indicating that this is a routine equity compensation grant rather than a signal of active trading activity.